Can adverse drug reactions be detected earlier? A comparison of reports by patients and professionals

BMJ

Volumn 313, Issue 7056, 1996, Pages 530-531

  Egberts, Toine C G ^a   Leufkens, Hubert G M ^a   Smulders, Maartje ^b   de Koning, Fred H P ^b   Meyboom, Ronald H B ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b Netherlands Pharmacovigilance Foundation LAREB   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; PAROXETINE;

ADVERSE DRUG REACTION; APATHY; ARTICLE; BLEEDING; DRUG MONITORING; EARLY DIAGNOSIS; FLUSHING; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MENSTRUATION DISORDER; MYDRIASIS; NETHERLANDS; PATIENT MONITORING; PHYSICIAN; PRIORITY JOURNAL; RASH; RIGOR; SELF REPORT; TASTE DISORDER;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTIDEPRESSIVE AGENTS; HUMANS; PAROXETINE; PATIENT PARTICIPATION; PROFESSIONAL PRACTICE; TIME FACTORS;

EID: 0029838837     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.313.7056.530     Document Type: Article

References (5)

1. Rossi AC, Knapp DE. Discovery of new adverse drug reactions. A review of the Food and Drug Administration's spontaneous reporting system. JAMA 1984; 252: 1030–1033.
2. Venning GR. Identification of adverse reactions to new drugs. III: Alerting processes and early warning systems. BMJ 1983; 286: 458–460.
3. Mitchell AS, Henry DA, Sanson-Fisher R, O'Connell DL. Patients as a direct source of information on adverse drug reactions. BMJ 1988; 297: 891–893.
4. Mann RD. Drug safety alerts. A review of “Current Problems.” Pharmacoepidemiology and Drug Safety 1992; 1: 269–279.
5. Haramburu F, Begaud B, Pere JC. Comparison of 500 spontaneous and 500 published reports of adverse drug reactions. Eur J Clin Pharmacol 1990; 39: 287–288.